ADI invites Biogen to present aducanumab data
This 75-minute webinar will present the data for Biogen’s investigational drug aducanumab, which if approved, would be the first disease-modifying treatment for Alzheimer’s disease.
News & events
News, conferences, events, blogs and updates from across the field of dementia and the work of Alzheimer's Disease International.
Featured news and events
World Alzheimer Report 2020: Design, Dignity, Dementia: dementia-related design and the built environment
Alzheimer’s Disease International (ADI) launches the world’s most comprehensive report on dementia-related design and the built environment.
Italian national dementia plan to receive funding for first time
Though Italy's National Dementia Plan was first approved in 2014, this is the first time that the plan will receive funding by the Italian government.
ADI’s 34th international and 1st virtual conference opens
ADI 2020 will take place from Thursday, 10 December until Saturday, 12 December and feature over 1,500 delegates from around the world.
Welcome to our new website
We have a new website, with updated design and content. The site works better on mobile devices and brings together our resources, member information and programmes so they are easy to find.
‘Dementia, lessons learned from Qatar’ launched at WISH 2020 Qatar Summit
A new policy briefing, co-authored by ADI, thoroughly examines dementia care policy in Qatar.
New Alzheimer’s disease data platform launched
A new data platform AD Workbench was launched by the Alzheimer’s Disease Data Initiative (ADDI).
Souvenaid results offer hope for those with early Alzheimer’s disease, including Mild Cognitive Impairment
Promising results from a clinical trial have been published in the peer-reviewed journal of the Alzheimer’s Association.
Evidence considered at FDA Advisory Committee for potential first new Alzheimer’s disease treatment in decades
The US Food and Drug Administration has reviewed clinical trial data for Biogen’s drug aducanumab, which aims to treat cognitive and functional decline in Alzheimer’s disease.
ADI, Global Coalition on Aging and Lien Foundation launch new Dementia Innovation Readiness Index
‘Dementia Innovation Readiness Index 2020: 30 Global Cities’ calls strongly for cities to fulfil their commitments under the WHO’s Global action plan on dementia to engage fully with their national dementia plans.